Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Motorola Solutions Inc (MSI) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance

Motorola Solutions IncTrade
State Street SPDR S&P Biotech ETFTrade

Price performance (Past 24H)

Key statistics

Motorola Solutions Inc vs State Street SPDR S&P Biotech ETF — how do they compare? Motorola Solutions Inc trades at $465.49 (market cap $77.26B), while State Street SPDR S&P Biotech ETF trades at $159.8. The key difference: Motorola Solutions Inc pays a 1.04% dividend while State Street SPDR S&P Biotech ETF pays none, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Motorola Solutions Inc nearer its low. Which is the better fit depends on your goals.

MSIXBI
Market Cap
$77.26B
Sector
TechnologyBroad Market / Factor
52-Week High
$490.30$164.28
52-Week Low
$363.83$86.92
Enterprise Value
$86.17B
Dividend Yield
1.04%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Motorola Solutions Inc

Motorola Solutions (MSI) trades at $461.98, down 1.19% today but has demonstrated strong momentum with three consecutive quarterly earnings beats and a 23.5% gain over three months. The company reported record Q2 2026 results with 13% revenue growth and raised full-year guidance, supported by a record $15.6 billion backlog. Technical indicators show a bullish trend with the stock near its pivot point of $463, while valuation metrics remain elevated with a P/E of 36.79.

The outlook remains positive given strong demand in public safety communications and software services, with analyst consensus pointing to 15% upside to the $533.80 price target. Key risks include execution challenges to meet elevated expectations and the premium valuation requiring sustained high growth. The combination of operational strength and bullish sentiment supports a constructive view for investors.

State Street SPDR S&P Biotech ETF

XBI trades at $159.15, up 0.71% with a bullish technical signal from moving averages. The biotech ETF shows strong momentum with a 17% monthly gain, driven by positive clinical data and M&A activity. Analyst coverage remains limited with a single hold rating, while institutional interest grows with recent $793,000 investment from Bay Colony Advisors.

Outlook remains positive given biotech sector resurgence, though elevated RSI suggests near-term overbought conditions. Key risks include sector volatility and regulatory uncertainty, but AI-driven drug discovery and strong pipeline developments provide growth catalysts for patient investors.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Motorola Solutions Inc

Motorola Solutions, Inc. is a data communications and telecommunications equipment provider. The Company develops data capture, wireless, infrastructure, bar code scanning, two-way radios, and wireless broadband networks. Motorola also produces public safety and government products, voice and data communications products and systems, and wireless LAN securities.

Read more on MSI

About State Street SPDR S&P Biotech ETF

XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.

Read more on XBI